Can civil lawsuits stem the tide of direct-to-consumer marketing of unproven stem cell interventions

The sale of unproven stem cell interventions (SCIs) by commercial entities has proliferated in highly developed countries, most notably in the USA. Yet, there have been few criminal prosecutions and regulatory enforcement actions against providers who have violated laws and best practice standards d...

Descripción completa

Detalles Bibliográficos
Autores principales: Horner, Claire, Tenenbaum, Evelyn, Sipp, Douglas, Master, Zubin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818472/
https://www.ncbi.nlm.nih.gov/pubmed/29479481
http://dx.doi.org/10.1038/s41536-018-0043-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818472/
https://www.ncbi.nlm.nih.gov/pubmed/29479481
http://dx.doi.org/10.1038/s41536-018-0043-6

Ejemplares similares